FDA Grants Tentative Approval for Generic Olaparib Tablets

The FDA has granted tentative approval for generic olaparib tablets, expanding access to this cancer treatment for patients with specific genetic mutations. This approval could lower treatment costs and improve accessibility for patients who need this medication. The move is significant in the context of cancer care and patient affordability.